GET DAILY SIGNALSCheck Point Software (CHKP): Can the Stock Reach the $160 Level?
Key Takeaways
- The central target discussed here is $160, which reflects the arithmetic mean of analyst price targets above the current price rather than the overall average.
- CHKP traded near $144 in early November 2026, so reaching $160 implies roughly an 11% gain — a modest move relative to the stock's 52-week range of about $112 to $232.
- The overall average of the reviewed targets sits near $150, essentially in line with the stock, while aggregators show a broad range from roughly $105 to $201 across more than 30 analysts.
- Supportive factors include 11% growth in security-subscriptions revenue, a $2.5 billion remaining-performance-obligations backlog, strong free cash flow, and an aggressive buyback.
- Key risks include declining product and maintenance revenue, currency headwinds, margin pressure, and a wave of analyst target cuts and downgrades during 2026.
- Readers can track the latest Major News and Today's Price Move for CHKP, review its Forecast, and follow its Earnings on dedicated pages.
- For a data-driven view of shifting market conditions, explore Trending AI Robots.
What Analysts Are Saying About CHKP
A review of roughly a dozen recent, individually attributed price targets — including Jefferies at $185, Robert W. Baird at $175, J.P. Morgan at $167, TD Cowen at $160, Bank of America at $160, Cantor Fitzgerald at $150, Yorkville Ives at $150, UBS and Mizuho at $145, Barclays at $140, RBC Capital and Wedbush at $135, and Wells Fargo at $130 — produces an arithmetic mean near $152. That figure sits almost exactly at the October 30 close, so it is not a meaningful upside objective. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Because the average is effectively at the market, the $160 central target used here is the rounded mean of only the targets that stand above the current price. Aggregators tracking 31 to 38 analysts show a full range of approximately $105 to $201, underscoring how divided the Street has become. Several firms cut targets sharply during 2026 — BofA Securities moved to Neutral and lowered its target from $260 to $120, while J.P. Morgan trimmed to $135 and Wedbush downgraded to Neutral in September 2026 — reflecting persistent caution about growth and execution.
Current Market Position and Path Toward the Target
With the stock near $144, reaching $160 requires roughly an 11% advance, a modest move by the standards of this stock's own volatility. The shares have fallen about 18% year-to-date but remain about 35% above their April 2026 low. Third-quarter results showed adjusted EPS of $2.49, in line with estimates, while revenue of $669.8 million missed the roughly $672 million consensus and declined about 1% year over year. Management said revenue likely troughed in the third quarter and expects gradual improvement from the fourth quarter, supported by a 12% to 20% price increase on firewall products and expected subscription revenue above $1.5 billion in 2027.
What Could Support a Move Toward the Target
The growth engine is shifting toward subscriptions, which rose 11% and now account for 51% of total revenue. Demand for email security, CTEM (Continuous Threat Exposure Management), and AI Security remains strong, with annual recurring revenue in these areas up more than 38%. Check Point generated $264 million in operating cash flow during the quarter, held $4.1 billion in cash, and repurchased $325 million of stock. At a trailing P/E near 15, the stock trades well below its five-year median multiple, which some analysts view as an undemanding entry point. From what I see, this valuation stands out as reasonable given the backlog.
What Could Prevent the Target From Being Reached
Product and maintenance revenue is still declining, and management flagged a softer firewall-appliance refresh cycle that could briefly weigh on subscription growth. A stronger Israeli shekel against the U.S. dollar has created an estimated $30 million operating-expense headwind year to date, with up to $50 million more possible in 2027. Gross margin dipped on higher memory costs, while operating expenses rose on workforce additions and AI and sales investments. Notably, the company saw zero positive and 33 negative EPS revisions over the prior 90 days, and the stock's momentum remains weak.
Technical Levels and Market Structure
The shares trade within a wide 52-week range of roughly $112 to $232. After the post-earnings pullback near $144, nearby support appears in the $135–$140 area, while $152–$155 marks a recent supply zone that would need to be reclaimed on the path toward $160. A sustained move above that level would represent a recovery of roughly half the distance back toward the stock's 2025 highs. I’m watching this closely as the stock tries to stabilize.
Time Horizon and What Investors Should Monitor
Analyst price targets typically reflect a roughly 12-month horizon. The most important near-term items are the fourth-quarter revenue and guidance trajectory, the durability of subscription growth, firewall refresh demand, currency trends, and the pace of share repurchases. Any analyst revisions following the third-quarter report will signal whether the Street believes the revenue trough and gradual recovery thesis.
Exploring AI Daily Buy/Sell Signals
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Explore the platform to see how these signals can complement your own research.
Final Assessment
Whether CHKP can reach $160 depends less on a single catalyst than on convincing the market that its growth reset is complete. The target represents the average of analyst targets above the current price and implies a modest 11% gain. Strong subscription momentum, a large backlog, healthy cash flow, and a discounted valuation support the case, while declining product revenue, currency pressure, and margin compression present real obstacles. With Street views spanning from $105 to $201, investors should watch fourth-quarter guidance and analyst revisions for evidence that the recovery thesis is taking hold.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CHKP's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CHKP turned positive on October 09, 2026. Looking at past instances where CHKP's MACD turned positive, the stock continued to rise in 37 of 51 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on CHKP as a result. In 60 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
CHKP moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHKP crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.
Following a +0.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHKP advanced for three days, in 189 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Aroon Indicator entered an Uptrend today. In 152 of 275 cases where CHKP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for CHKP moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 15 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 79 cases where CHKP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHKP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
CHKP broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. CHKP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.674) is normal, around the industry mean (16.752). P/E Ratio (15.365) is within average values for comparable stocks, (58.881). Projected Growth (PEG Ratio) (1.145) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.269) among similar stocks. P/S Ratio (5.322) is also within normal values, averaging (103.889).
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHKP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of network security software products
Industry ComputerCommunications
Advertisement